These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9581911)

  • 1. A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis.
    Wagner JA; Moran ML; Messner AH; Daifuku R; Conrad CK; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Hum Gene Ther; 1998 Apr; 9(6):889-909. PubMed ID: 9581911
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease.
    Flotte T; Carter B; Conrad C; Guggino W; Reynolds T; Rosenstein B; Taylor G; Walden S; Wetzel R
    Hum Gene Ther; 1996 Jun; 7(9):1145-59. PubMed ID: 8773517
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cystic fibrosis and gene therapy].
    Setoguchi Y; Yokoyama T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():607-16. PubMed ID: 16416861
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal expression of the cystic fibrosis transmembrane regulator in chronic sinusitis in cystic fibrosis and non-cystic fibrosis patients.
    Coltrera MD; Mathison SM; Goodpaster TA; Gown AM
    Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):576-81. PubMed ID: 10378526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology evaluation: AAV-CFTR vector, targeted genetics.
    Tebbutt SJ
    Curr Opin Mol Ther; 1999 Aug; 1(4):524-9. PubMed ID: 11713770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.
    Wagner JA; Nepomuceno IB; Messner AH; Moran ML; Batson EP; Dimiceli S; Brown BW; Desch JK; Norbash AM; Conrad CK; Guggino WB; Flotte TR; Wine JJ; Carter BJ; Reynolds TC; Moss RB; Gardner P
    Hum Gene Ther; 2002 Jul; 13(11):1349-59. PubMed ID: 12162817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breathing Easier: Molecular Therapeutics for Cystic Fibrosis.
    Limberis MP
    Hum Gene Ther; 2020 Sep; 31(17-18):905-906. PubMed ID: 32945723
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis.
    Carter BJ; Flotte TR
    Curr Top Microbiol Immunol; 1996; 218():119-44. PubMed ID: 8794249
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
    Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
    Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laying the Foundation for Cystic Fibrosis Therapy: An Interview with Michael Boyle.
    Davies K
    Hum Gene Ther; 2020 Sep; 31(17-18):917-920. PubMed ID: 32924627
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
    Flotte TR
    Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhinosinusitis in the pediatric patient with cystic fibrosis.
    Fundakowski C; Ojo R; Younis R
    Curr Pediatr Rev; 2014; 10(3):198-201. PubMed ID: 25088340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward cystic fibrosis gene therapy.
    Wagner JA; Gardner P
    Annu Rev Med; 1997; 48():203-16. PubMed ID: 9046956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
    Guggino WB; Cebotaru L
    Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus.
    Wagner JA; Reynolds T; Moran ML; Moss RB; Wine JJ; Flotte TR; Gardner P
    Lancet; 1998 Jun; 351(9117):1702-3. PubMed ID: 9734891
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
    Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
    Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy for Respiratory Diseases: Progress and a Changing Context.
    Alton EWFW; Boyd AC; Davies JC; Gill DR; Griesenbach U; Harman TE; Hyde S; McLachlan G
    Hum Gene Ther; 2020 Sep; 31(17-18):911-916. PubMed ID: 32746737
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of nonviral vectors for cystic fibrosis gene therapy.
    Alton EW;
    Proc Am Thorac Soc; 2004; 1(4):296-301. PubMed ID: 16113449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.